Condizione: As New. Illustrated By Posy Simmonds (illustratore). Unread book in perfect condition.
Condizione: New. Illustrated By Posy Simmonds (illustratore).
EUR 15,19
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Illustrated By Posy Simmonds (illustratore).
EUR 17,26
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: As New. Illustrated By Posy Simmonds (illustratore). Unread book in perfect condition.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Condizione: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
Condizione: New.
Condizione: New. 5th edition NO-PA16APR2015-KAP.
EUR 225,38
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New.
EUR 225,85
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New.
Condizione: As New. Unread book in perfect condition.
EUR 232,23
Quantità: 10 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Taylor & Francis Ltd, London, 2023
ISBN 10: 1032202203 ISBN 13: 9781032202204
Da: Grand Eagle Retail, Bensenville, IL, U.S.A.
Hardcover. Condizione: new. Hardcover. Cystic Fibrosis has seen dramatic advances in treatment since the last edition, including targeted cystic fibrosis transmembrane conductance regulator (CFTR) protein modulators for most CFTR gene abnormalities. This new fifth edition is an update and expansion of the rapid clinical and scientific advances in improving prognosis, and the impact of COVID-19, all of which has transformed conventional models of care. It covers basic science, such as how detailed understanding of the biology of the CFTR gene and protein has led to novel and beneficial therapies, as well as all aspects of clinical management in high-, middle- and low-income settings and the voices of individuals with CF from across the world. It will be a useful reference for clinicians, including all levels of trainees, across the whole multidisciplinary team, scientists and students.Key Features Follows an appealing organization of chapters, by developing fundamental knowledge of the reader before moving on to more complex or developing topics. Presents a comprehensive, authoritative and up-to-date text, integrating fundamental science and clinical aspects of cystic fibrosis providing an attractive read for clinicians, trainee doctors and scientists. Draws on global expertise and reflects best evidence-based practice from experts conducting cutting-edge clinical and basic science research from around the world. Cystic Fibrosis has seen dramatic advances in treatment since the last edition, including targeted CFTR protein modulators for most CFTR gene abnormalities. This new edition is an update of the rapid clinical and scientific advances in improving prognosis, and the impact of CoVID-19, which has transformed conventional models of care. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
EUR 246,93
Quantità: 10 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
EUR 239,03
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Andrew Bush MD FHEA FRCP FRCPCH FERS FAPSR ATSFProfessor of Paediatrics and Paediatric Respirology, National Heart and Lung Institute, and Imperial Centre for Paediatrics and Child Health, Imperial CollegeConsultant Paediatric Chest .
Lingua: Inglese
Editore: Taylor & Francis Ltd, London, 2023
ISBN 10: 1032202203 ISBN 13: 9781032202204
Da: AussieBookSeller, Truganina, VIC, Australia
EUR 293,17
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: new. Hardcover. Cystic Fibrosis has seen dramatic advances in treatment since the last edition, including targeted cystic fibrosis transmembrane conductance regulator (CFTR) protein modulators for most CFTR gene abnormalities. This new fifth edition is an update and expansion of the rapid clinical and scientific advances in improving prognosis, and the impact of COVID-19, all of which has transformed conventional models of care. It covers basic science, such as how detailed understanding of the biology of the CFTR gene and protein has led to novel and beneficial therapies, as well as all aspects of clinical management in high-, middle- and low-income settings and the voices of individuals with CF from across the world. It will be a useful reference for clinicians, including all levels of trainees, across the whole multidisciplinary team, scientists and students.Key Features Follows an appealing organization of chapters, by developing fundamental knowledge of the reader before moving on to more complex or developing topics. Presents a comprehensive, authoritative and up-to-date text, integrating fundamental science and clinical aspects of cystic fibrosis providing an attractive read for clinicians, trainee doctors and scientists. Draws on global expertise and reflects best evidence-based practice from experts conducting cutting-edge clinical and basic science research from around the world. Cystic Fibrosis has seen dramatic advances in treatment since the last edition, including targeted CFTR protein modulators for most CFTR gene abnormalities. This new edition is an update of the rapid clinical and scientific advances in improving prognosis, and the impact of CoVID-19, which has transformed conventional models of care. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Lingua: Inglese
Editore: TAYLOR & FRANCIS NP EXCLUSIVE(CBS), 2024
ISBN 10: 1032202203 ISBN 13: 9781032202204
Da: UK BOOKS STORE, London, LONDO, Regno Unito
EUR 352,17
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
Lingua: Inglese
Editore: Taylor & Francis Ltd Okt 2023, 2023
ISBN 10: 1032202203 ISBN 13: 9781032202204
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 296,98
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Neuware - Cystic Fibrosis has seen dramatic advances in treatment since the last edition, including targeted CFTR protein modulators for most CFTR gene abnormalities. This new edition is an update of the rapid clinical and scientific advances in improving prognosis, and the impact of CoVID-19, which has transformed conventional models of care.